National Health Amendment (Cheaper Medicines) Act 2025

Overview

The National Health Amendment (Cheaper Medicines) Act 2025, enacted by the Parliament of Australia, is designed to amend the National Health Act 1953 with the primary objective of reducing the cost of prescription medicines for Australian consumers. The Act aims to address the gap in affordability and accessibility of essential medications by adjusting the pricing mechanisms and general patient charge amounts. The provisions of this Act are set to commence on 1 January 2026, ensuring a systematic transition that aligns with the legislative intent to improve healthcare affordability without immediate disruption. The overarching policy objective is to enhance the financial viability of prescription medications, thereby promoting better health outcomes for the Australian population.

Scope and Application

The National Health Amendment (Cheaper Medicines) Act 2025 amends the National Health Act 1953 to adjust the pricing mechanisms for medicines provided under the national health scheme. This legislation applies to all persons and entities involved in the provision or administration of medicines under the national health scheme, including pharmaceutical companies, healthcare providers, and patients. It does not specify exclusions but implicitly applies to all transactions involving prescribed medications within the scheme. The Act’s provisions are effective from 1 January 2026, as stipulated in the commencement section, and it has a national reach across Australia, impacting both Commonwealth and state-level healthcare services. The Act also provides for further amendments or regulations through subordinate instruments, which may specify additional details or operational guidelines for the changes introduced.

Key Provisions

The National Health Amendment (Cheaper Medicines) Act 2025 amends the National Health Act 1953 primarily by reducing the general patient charge amount from $30.00 to $25.00 (section 1). It also removes the provision for allowable discounts on the general patient charge amount, ensuring that the charge is fixed at $25.00 without any deductions (sections 2 and 3). The Act removes the reference to the lowest amount chargeable under subparagraph (i) and replaces it with the general patient charge amount, which is now set at $25.00 (section 4). Additionally, it repeals the note in subsection 87(2) and omits the reference to any allowable discount in subsection 99(2C) (sections 4 and 5). The Act also extends the application of a specific provision from 1 January 2025 to 1 January 2026 and repeals section 99GC and the corresponding reference in section 99GE (sections 6, 7 and 8). The Act imposes several obligations on the parties governed by it, including the requirement to charge the new general patient charge amount of $25.00 for specific services (subsection 84(1)). Healthcare providers must ensure that this charge is applied consistently without any allowable discounts (sections 2 and 3). The changes also mean that any references to the lowest amount chargeable under subparagraph (i) must now be interpreted as the general patient charge amount of $25.00 (section 4). Furthermore, the repeal of section 99GC and the associated note in subsection 99(2C) means that any provisions relying on these sections must be updated to reflect the changes made by the Act (sections 5, 7 and 8). For breaches of the provisions set out in the National Health Amendment (Cheaper Medicines) Act 2025, the Act does not explicitly state specific offences or penalties. However, under the National Health Act 1953, penalties for non-compliance can include fines and, in severe cases, criminal charges. The exact penalties would depend on the specific nature of the breach and would be subject to the relevant provisions of the National Health Act 1953 and other applicable laws. It is important for healthcare providers and other affected parties to ensure compliance with the new provisions to avoid any potential penalties or legal consequences.